ShareValue.ai

ShareValue scores for CBLL: Valuation 44, Quality 44, Growth 69, Health 40.

CBLL
NASDAQ

CeriBell, Inc

$18.15(-1.25%)
Loading chart...
Sentiment

Verdicts

Rating

Trap Risk

Return

3% to 17%
Valuation
44
Fair Value
Price vs Value
Quality
44
Moderate
Business Strength
Growth
69
Moderate
Revenue & Earnings
Health
40
Stressed
Financial Stability
Momentum
62
Bullish
Price Trend

Company Details

About

CeriBell, Inc. operates as a medical technology company in the United States. It develops the Ceribell System, a novel and point-of-care EEG platform specifically designed to address the unmet needs of patients in the acute care setting. The company also offers disposable, flexible headbands, and headcaps; and a pocket-sized, rechargeable battery-operated recorder used to capture and wirelessly transmit EEG signals; and Clarity, an AI-powered seizure detection algorithm. In addition, it operates an EEG portal, which enables real-time remote access to a patient's EEG data. The company was formerly known as Brain Stethoscope, Inc. and changed its name to CeriBell, Inc. in August 2015. CeriBell, Inc. was incorporated in 2014 and is headquartered in Sunnyvale, California.

Score Analysis

AI Investment Thesis

Data as of:Jun 12, 2026
|
Last calculated:Jun 12, 2026